Matteo Cassandri | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma	CANCERS	2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks	CELL DEATH DISCOVERY	2024
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma	BMC CANCER	2024
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY	2023
DNA repair in tumor radioresistance: insights from fruit flies genetics	CELLULAR ONCOLOGY	2023
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles	MUSCLES	2023
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting	NATURE COMMUNICATIONS	2023
ZFP750 affects the cutaneous barrier through regulating lipid metabolism	SCIENCE ADVANCES	2023
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression	FRONTIERS IN ONCOLOGY	2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose	FRONTIERS IN ONCOLOGY	2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo	FRONTIERS IN PHARMACOLOGY	2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors	CELLS	2022
Abstract 668: A MYOD-SKP2 axis boosts oncogenic properties of fusion negative rhabdomyosarcoma and is counteracted by neddylation inhibition in vitro and in vivo	CANCER RESEARCH	2022
New Insights on the Nuclear Functions and Targeting of {FAK} in Cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma	NATURE COMMUNICATIONS	2021
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor	CELL DEATH & DISEASE	2021
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma	CELLS	2021